VERQUVO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Verquvo, and when can generic versions of Verquvo launch?
Verquvo is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are six patents protecting this drug.
This drug has two hundred and ten patent family members in forty-nine countries.
The generic ingredient in VERQUVO is vericiguat. One supplier is listed for this compound. Additional details are available on the vericiguat profile page.
DrugPatentWatch® Generic Entry Outlook for Verquvo
Verquvo will be eligible for patent challenges on January 19, 2025. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be November 26, 2032. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERQUVO?
- What are the global sales for VERQUVO?
- What is Average Wholesale Price for VERQUVO?
Summary for VERQUVO
| International Patents: | 210 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 2 |
| Patent Applications: | 125 |
| Drug Prices: | Drug price information for VERQUVO |
| What excipients (inactive ingredients) are in VERQUVO? | VERQUVO excipients list |
| DailyMed Link: | VERQUVO at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for VERQUVO
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VERQUVO
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins University | Phase 2 |
| Merck Sharp & Dohme LLC | Phase 2 |
| Josef Stehlik | Phase 4 |
Pharmacology for VERQUVO
| Drug Class | Soluble Guanylate Cyclase Stimulator |
| Mechanism of Action | Guanylate Cyclase Stimulators |
US Patents and Regulatory Information for VERQUVO
VERQUVO is protected by six US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of VERQUVO is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting VERQUVO
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: REDUCING THE RISK OF CARDIOVASCULAR DEATH AND HEART FAILURE (HF) HOSPITALIZATION FOLLOWING A HOSPITALIZATION FOR HF OR NEED FOR OUTPATIENT IV DIURETICS, IN ADULTS WITH SYMPTOMATIC CHRONIC HF AND EJECTION FRACTION LESS THAN 45%
Substituted 5-fluoro-1H-pyrazolopyridines and their use
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: REDUCING THE RISK OF CARDIOVASCULAR DEATH AND HEART FAILURE (HF) HOSPITALIZATION FOLLOWING A HOSPITALIZATION FOR HF OR NEED FOR OUTPATIENT IV DIURETICS, IN ADULTS WITH SYMPTOMATIC CHRONIC HF AND EJECTION FRACTION LESS THAN 45%
Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: REDUCING THE RISK OF CARDIOVASCULAR DEATH AND HEART FAILURE (HF) HOSPITALIZATION FOLLOWING A HOSPITALIZATION FOR HF OR NEED FOR OUTPATIENT IV DIURETICS, IN ADULTS WITH SYMPTOMATIC CHRONIC HF AND EJECTION FRACTION LESS THAN 45%
Substituted 5-flouro-1H-pyrazolopyridines and their use
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: REDUCING THE RISK OF CARDIOVASCULAR DEATH AND HEART FAILURE (HF) HOSPITALIZATION FOLLOWING A HOSPITALIZATION FOR HF OR NEED FOR OUTPATIENT IV DIURETICS, IN ADULTS WITH SYMPTOMATIC CHRONIC HF AND EJECTION FRACTION LESS THAN 45%
FDA Regulatory Exclusivity protecting VERQUVO
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | VERQUVO | vericiguat | TABLET;ORAL | 214377-001 | Jan 19, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | VERQUVO | vericiguat | TABLET;ORAL | 214377-003 | Jan 19, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | VERQUVO | vericiguat | TABLET;ORAL | 214377-001 | Jan 19, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | VERQUVO | vericiguat | TABLET;ORAL | 214377-001 | Jan 19, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck Sharp Dohme | VERQUVO | vericiguat | TABLET;ORAL | 214377-002 | Jan 19, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for VERQUVO
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Bayer AG | Verquvo | vericiguat | EMEA/H/C/005319 Treatment of symptomatic chronic heart failure |
Authorised | no | no | no | 2021-07-16 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for VERQUVO
When does loss-of-exclusivity occur for VERQUVO?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
African Regional IP Organization (ARIPO)
Patent: 98
Patent: Method for producing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Argentina
Patent: 8983
Patent: PROCEDIMIENTO PARA LA PREPARACION DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 5027
Patent: PROCEDIMIENTO PARA LA PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Australia
Patent: 12342547
Patent: Method for producing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 17254916
Patent: Method for producing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 19202123
Patent: Method for producing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Brazil
Patent: 2014012414
Patent: processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas
Estimated Expiration: ⤷ Sign Up
Patent: 2020001312
Patent: Processo para preparação de 5-flúor-1h-pirazolopiridinas substituídas, e compostos intermediários
Estimated Expiration: ⤷ Sign Up
Canada
Patent: 56706
Patent: PROCEDE DE PRODUCTION DE 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUEES (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 40720
Patent: PROCEDE DE PRODUCTION DE 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUEES (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Chile
Patent: 14001339
Patent: Procedimiento de preparacion de un compuesto intermediario derivado de 5-fluoro-1h-pirazolopiridina; compuestos intermediarios que participan del mismo y formas cristalinas del compuesto final obtenido, el cual es util en el tratamiento de trastornos cardiocirculatorios.
Estimated Expiration: ⤷ Sign Up
Patent: 16000344
Patent: Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
Estimated Expiration: ⤷ Sign Up
China
Patent: 4159898
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 5503867
Patent: Method for producing substituted 5-fluoro-lH-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 6905314
Patent: 用于制备取代的5‑氟‑1H‑吡唑并吡啶类化合物的方法 (Method for producing substituted 5-fluoro-1H-pyrazolopyridines)
Estimated Expiration: ⤷ Sign Up
Colombia
Patent: 60555
Patent: Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
Estimated Expiration: ⤷ Sign Up
Costa Rica
Patent: 140237
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 190057
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS (Divisional 2014-0237) (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 210072
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Croatia
Patent: 0161501
Estimated Expiration: ⤷ Sign Up
Patent: 0181818
Estimated Expiration: ⤷ Sign Up
Patent: 0210507
Estimated Expiration: ⤷ Sign Up
Cuba
Patent: 257
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5- FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 354
Patent: PROCEDIMIENTO DE OBTENCIÓN DE DERIVADOS DE TETRAFLUOROPROPILMORFOLINA
Estimated Expiration: ⤷ Sign Up
Patent: 140055
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5- FLUORO- 1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 150123
Patent: DOS FORMAS CRISTALINAS DEL COMPUESTO( 4,6-DIAMINO-2-(5-FLUORO-1-(2-FLUOROBENCIL)-1H-PIRAZOLO?(3,4-b)PIRIDIN-3-IL)PIRIMIDIN-5-IL)CARBAMATO DE METILO
Estimated Expiration: ⤷ Sign Up
Patent: 150124
Patent: PROCEDIMIENTO DE OBTENCIÓN DE DERIVADOS DE TETRAFLUOROPROPILMORFOLINA
Estimated Expiration: ⤷ Sign Up
Cyprus
Patent: 24000
Estimated Expiration: ⤷ Sign Up
Denmark
Patent: 82914
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Estimated Expiration: ⤷ Sign Up
Dominican Republic
Patent: 014000112
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 017000013
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 021000179
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Ecuador
Patent: 14001627
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Eurasian Patent Organization
Patent: 0018
Patent: СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННОГО 5-ФТОР-1H-ПИРАЗОЛОПИРИДИНА (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINE)
Estimated Expiration: ⤷ Sign Up
Patent: 1602
Patent: СПОСОБЫ ПОЛУЧЕНИЯ АЛЬДЕГИДОВ (PROCESSES FOR PRERARING ALDEHYDES)
Estimated Expiration: ⤷ Sign Up
Patent: 3455
Patent: КРИСТАЛЛИЧЕСКИЕ ФОРМЫ ЗАМЕЩЕННЫХ 5-ФТОР-1H-ПИРАЗОЛОПИРИДИНОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБ ЛЕЧЕНИЯ НА ИХ ОСНОВЕ (CRYSTALLINE FORMS OF SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES, PROCESSES FOR PREPARING SAME, USE THEREOF FOR PRODUCING A MEDICAMENT, MEDICAMENT AND METHOD OF TREATMENT BASED THEREOF)
Estimated Expiration: ⤷ Sign Up
Patent: 1491028
Patent: СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ 5-ФТОР-1Н-ПИРАЗОЛОПИРИДИНОВ
Estimated Expiration: ⤷ Sign Up
Patent: 1690520
Patent: СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ 5-ФТОР-1H-ПИРАЗОЛОПИРИДИНОВ
Estimated Expiration: ⤷ Sign Up
Patent: 1690521
Patent: СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ 5-ФТОР-1H-ПИРАЗОЛОПИРИДИНОВ
Estimated Expiration: ⤷ Sign Up
Patent: 1892050
Patent: СПОСОБ ПОЛУЧЕНИЯ ЗАМЕЩЕННЫХ 5-ФТОР-1H-ПИРАЗОЛОПИРИДИНОВ
Estimated Expiration: ⤷ Sign Up
European Patent Office
Patent: 82914
Patent: PROCÉDÉ DE PRODUCTION DE 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUÉES (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Patent: PROCÉDÉ DE PRODUCTION DE (Z)-ALPHA-FLUORO-BETA-AMINO-ACRYLALDEHYDES SUBSTITUÉES (METHOD FOR PRODUCING SUBSTITUTED (Z)-ALPHA-FLUORO-BETA-AMINO-ACRYLALDEHYDES)
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Patent: 5-FLUORO-1H-PYRAZOLOPYRIDINES SUBSTITUÉES SOUS FORME CRISTALLINE (SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM)
Estimated Expiration: ⤷ Sign Up
Guatemala
Patent: 1400101
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Hong Kong
Patent: 03951
Patent: 用於製備取代的 -氟- -吡唑並吡啶類化合物的方法 (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES 5--1H-)
Estimated Expiration: ⤷ Sign Up
Patent: 23613
Patent: 用於製備取代的 -氟- -吡唑並吡啶類化合物的方法 (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES 5--1H-)
Estimated Expiration: ⤷ Sign Up
Hungary
Patent: 31029
Estimated Expiration: ⤷ Sign Up
Patent: 41592
Estimated Expiration: ⤷ Sign Up
Patent: 53745
Estimated Expiration: ⤷ Sign Up
Israel
Patent: 6265
Patent: שיטה לייצור חומרי ביניים להכנת 5-פלואורו-h1-פיראזולופירידינים ותרכובות שכאלה (Process for preparing intermediates for the preparation of 5-fluoro-1h-pyrazolopyridines and some such compounds)
Estimated Expiration: ⤷ Sign Up
Patent: 3389
Patent: שיטה לייצור 5-פלואורו-1h-פיראזולופירידינים מותמרים (Method for producing substituted 5-fluoro-1h-pyrazolopyridines)
Estimated Expiration: ⤷ Sign Up
Japan
Patent: 89315
Estimated Expiration: ⤷ Sign Up
Patent: 40391
Estimated Expiration: ⤷ Sign Up
Patent: 92436
Estimated Expiration: ⤷ Sign Up
Patent: 15502932
Patent: 置換された５−フルオロ−１Ｈ−ピラゾロピリジン類を製造するための方法
Estimated Expiration: ⤷ Sign Up
Patent: 17031180
Patent: 置換された５−フルオロ−１Ｈ−ピラゾロピリジン類を製造するための方法 (PROCESS FOR PREPARING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 18058860
Patent: 置換された５−フルオロ−１Ｈ−ピラゾロピリジン類を製造するための方法 (PROCESS FOR PREPARING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 18199698
Patent: 置換された５−フルオロ−１Ｈ−ピラゾロピリジン類を製造するための方法 (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLO PYRIDINES)
Estimated Expiration: ⤷ Sign Up
Jordan
Patent: 0120351
Patent: عملية لتحضير 5- فلورو-1H- بيرازولوبيريدينات مستبدلة (Process for preparing substituted 5-fluoro-1H-pyrazolopyridines)
Estimated Expiration: ⤷ Sign Up
Patent: 0210064
Patent: عملية لتحضير 5- فلورو-1H- بيرازولوبيريدينات مستبدلة (Process for preparing substituted 5-fluoro-1H-pyrazolopyridines)
Estimated Expiration: ⤷ Sign Up
Patent: 0210065
Patent: عملية لتحضير 5- فلورو-1H- بيرازولوبيريدينات مستبدلة (Process for preparing substituted 5-fluoro-1H-pyrazolopyridines)
Estimated Expiration: ⤷ Sign Up
Lithuania
Patent: 82914
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Estimated Expiration: ⤷ Sign Up
Malaysia
Patent: 8412
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 7904
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 8086
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Mexico
Patent: 7481
Patent: PROCEDIMIENTO DE PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS. (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES.)
Estimated Expiration: ⤷ Sign Up
Patent: 14006018
Patent: PROCEDIMIENTO DE PREPARACION DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS. (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES.)
Estimated Expiration: ⤷ Sign Up
Morocco
Patent: 718
Patent: Procédé de production de 5-fluoro-1h-pyrazolopyridines substituées
Estimated Expiration: ⤷ Sign Up
New Zealand
Patent: 4593
Patent: Method for producing substituted 5-fluoro-1h-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 1592
Patent: Method for producing substituted 5-fluoro-1h-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 4215
Patent: Method for producing substituted 5-fluoro-1h-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Peru
Patent: 142359
Patent: PROCEDIMIENTO DE PREPARACION DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 190180
Patent: PROCEDIMIENTO DE PREPARACION DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 190181
Patent: PROCEDIMIENTO DE PREPARACION DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Philippines
Patent: 014501160
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H - PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 015501494
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIMIDINES
Estimated Expiration: ⤷ Sign Up
Poland
Patent: 82914
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Estimated Expiration: ⤷ Sign Up
Portugal
Patent: 82914
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Estimated Expiration: ⤷ Sign Up
Serbia
Patent: 387
Patent: POSTUPAK ZA DOBIJANJE SUPSTITUISANIH (Z)-ALFA-FLUORO-BETA-AMINO-AKRILALDEHIDA (METHOD FOR PRODUCING SUBSTITUTED (Z)-ALPHA-FLUORO-BETA-AMINO-ACRYLALDEHYDES)
Estimated Expiration: ⤷ Sign Up
Patent: 945
Patent: POSTUPAK ZA DOBIJANJE SUPSTITUISANIH 5-FLUORO-1H-PIRAZOLOPIRADINA (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 609
Patent: SUPSTITUISANI 5-FLUOR-1H-PIRAZOLOPIRIDIN U KRISTALNOM OBLIKU (SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM)
Estimated Expiration: ⤷ Sign Up
Singapore
Patent: 201604192X
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 201604196V
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 201402111Q
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Slovenia
Patent: 82914
Estimated Expiration: ⤷ Sign Up
Patent: 96617
Estimated Expiration: ⤷ Sign Up
Patent: 21470
Estimated Expiration: ⤷ Sign Up
South Africa
Patent: 1403613
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 1505970
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
South Korea
Patent: 1943788
Estimated Expiration: ⤷ Sign Up
Patent: 1993022
Estimated Expiration: ⤷ Sign Up
Patent: 2026059
Estimated Expiration: ⤷ Sign Up
Patent: 140105483
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Patent: 170130612
Patent: 치환된 5-플루오로-1H-피라졸로피리딘의 제조 방법 (5--1H- METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 190018021
Patent: 치환된 5-플루오로-1H-피라졸로피리딘의 제조 방법 (5--1H- METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Spain
Patent: 03028
Estimated Expiration: ⤷ Sign Up
Patent: 94158
Estimated Expiration: ⤷ Sign Up
Patent: 64009
Estimated Expiration: ⤷ Sign Up
Taiwan
Patent: 97280
Estimated Expiration: ⤷ Sign Up
Patent: 31123
Estimated Expiration: ⤷ Sign Up
Patent: 59016
Estimated Expiration: ⤷ Sign Up
Patent: 65198
Estimated Expiration: ⤷ Sign Up
Patent: 1329076
Patent: Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 1708219
Patent: Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 1831447
Patent: Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 1838993
Patent: Process for preparing substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Patent: 1932465
Patent: Processes for preparing intermediates of substituted 5-fluoro-1H-pyrazolopyridines
Estimated Expiration: ⤷ Sign Up
Tunisia
Patent: 14000227
Patent: METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
Estimated Expiration: ⤷ Sign Up
Turkey
Patent: 1816203
Estimated Expiration: ⤷ Sign Up
Ukraine
Patent: 6623
Patent: СПОСІБ ОДЕРЖАННЯ ЗАМІЩЕНИХ 5-ФТОР-1H-ПІРАЗОЛОПІРИДИНІВ (METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES)
Estimated Expiration: ⤷ Sign Up
Patent: 9269
Patent: СПОСІБ ОДЕРЖАННЯ ПРОМІЖНИХ СПОЛУК В СПОСОБІ ОДЕРЖАННЯ ЗАМІЩЕНИХ 5-ФТОР-1Н-ПІРАЗОЛОПІРИДИНІВ
Estimated Expiration: ⤷ Sign Up
Patent: 0278
Patent: ЗАМІЩЕНІ 5-ФТОР-1Н-ПІРАЗОЛОПІРИДИНИ В КРИСТАЛІЧНІЙ ФОРМІ
Estimated Expiration: ⤷ Sign Up
Uruguay
Patent: 467
Patent: PROCEDIMIENTO PARA LA PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Patent: 646
Patent: PROCEDIMIENTO PARA LA PREPARACIÓN DE 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS
Estimated Expiration: ⤷ Sign Up
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering VERQUVO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Brazil | 112014012414 | processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas | ⤷ Sign Up |
| South Korea | 20190018021 | 치환된 5-플루오로-1H-피라졸로피리딘의 제조 방법 (5--1H- METHOD FOR PRODUCING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES) | ⤷ Sign Up |
| Portugal | 2896617 | ⤷ Sign Up | |
| Cuba | 24086 | 5-FLUORO-1H-PIRAZOLOPIRIDINAS SUSTITUIDAS | ⤷ Sign Up |
| South Korea | 20130116001 | THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF SYSTEMIC SCLEROSIS (SSC) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VERQUVO
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2576547 | 301146 | Netherlands | ⤷ Sign Up | PRODUCT NAME: VERICIGUAT; REGISTRATION NO/DATE: EU/1/21/1561 20210720 |
| 2576547 | 2190031-1 | Sweden | ⤷ Sign Up | PRODUCT NAME: VERICIGUAT AND ITS SALTS, SOLVATES AND SOLVATES OF THE SALTS; REG. NO/DATE: EU/1/21/1561 20210720 |
| 2576547 | CR 2021 00032 | Denmark | ⤷ Sign Up | PRODUCT NAME: VERICIGUAT OG DETS SALTE, SOLVATER OG SOLVATER AF SALTENE; REG. NO/DATE: EU/1/21/1561 20210720 |
| 2576547 | C202130044 | Spain | ⤷ Sign Up | PRODUCT NAME: VERICIGUAT Y SUS SALES, SOLVATOS Y SOLVATOS DE LAS SALES.; NATIONAL AUTHORISATION NUMBER: EU/1/21/1561; DATE OF AUTHORISATION: 20210716; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1561; DATE OF FIRST AUTHORISATION IN EEA: 20210716 |
| 2576547 | 2021C/553 | Belgium | ⤷ Sign Up | PRODUCT NAME: VERICIGUAT EN ZIJN ZOUTEN, SOLVATEN EN SOLVATEN VAN DE ZOUTEN; AUTHORISATION NUMBER AND DATE: EU/1/21/1561 20210720 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
